142 related articles for article (PubMed ID: 12915198)
1. (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors.
Cho YD; Choi GH; Lee SP; Kim JK
Magn Reson Imaging; 2003 Jul; 21(6):663-72. PubMed ID: 12915198
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of intracranial meningiomas based on magnetic resonance spectroscopy.
Jaskólski DJ; Fortuniak J; Stefańczyk L; Majos A; Gajewicz W; Papierz W; Liberski PP; Sikorska B
Neurol Neurochir Pol; 2013; 47(3):247-55. PubMed ID: 23821422
[TBL] [Abstract][Full Text] [Related]
3. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
[TBL] [Abstract][Full Text] [Related]
4. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.
Hazany S; Hesselink JR; Healy JF; Imbesi SG
Neuroradiology; 2007 Feb; 49(2):121-7. PubMed ID: 17086406
[TBL] [Abstract][Full Text] [Related]
5. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Kinoshita Y; Yokota A
NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
[TBL] [Abstract][Full Text] [Related]
6. Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas.
Majós C; Alonso J; Aguilera C; Serrallonga M; Coll S; Acebes JJ; Arús C; Gili J
Neuroradiology; 2003 Mar; 45(3):129-36. PubMed ID: 12684713
[TBL] [Abstract][Full Text] [Related]
7. New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma.
Yue Q; Isobe T; Shibata Y; Anno I; Kawamura H; Yamamoto Y; Takano S; Matsumura A
Eur Radiol; 2008 Dec; 18(12):2901-11. PubMed ID: 18641997
[TBL] [Abstract][Full Text] [Related]
8. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588
[TBL] [Abstract][Full Text] [Related]
9. Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS.
Opstad KS; Provencher SW; Bell BA; Griffiths JR; Howe FA
Magn Reson Med; 2003 Apr; 49(4):632-7. PubMed ID: 12652533
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms.
Tugnoli V; Tosi MR; Barbarella G; Ricci R; Leonardi M; Calbucci F; Bertoluzza A
Oncol Rep; 1998; 5(5):1199-203. PubMed ID: 9683835
[TBL] [Abstract][Full Text] [Related]
11. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
12. In vivo proton magnetic resonance spectroscopy of human spinal mass lesions.
Kim YG; Choi GH; Kim DH; Kim YD; Kang YK; Kim JK
J Spinal Disord Tech; 2004 Oct; 17(5):405-11. PubMed ID: 15385881
[TBL] [Abstract][Full Text] [Related]
13. (1)H MR Spectroscopy of Meningiomas at 3.0T: the Role of Glutamate-Glutamine Complex and Glutathione.
Crisi G
Neuroradiol J; 2011 Dec; 24(6):846-53. PubMed ID: 24059885
[TBL] [Abstract][Full Text] [Related]
14. In vivo MRS study of intraventricular tumors.
Shah T; Jayasundar R; Singh VP; Sarkar C
J Magn Reson Imaging; 2011 Nov; 34(5):1053-9. PubMed ID: 22002756
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.
Howe FA; Barton SJ; Cudlip SA; Stubbs M; Saunders DE; Murphy M; Wilkins P; Opstad KS; Doyle VL; McLean MA; Bell BA; Griffiths JR
Magn Reson Med; 2003 Feb; 49(2):223-32. PubMed ID: 12541241
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
17. Dynamic MRI of meningiomas and schwannomas: is differential diagnosis possible?
Ikushima I; Korogi Y; Kuratsu J; Hirai T; Hamatake S; Takahashi M; Ushio Y
Neuroradiology; 1997 Sep; 39(9):633-8. PubMed ID: 9335061
[TBL] [Abstract][Full Text] [Related]
18. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of quantitative proton MR spectroscopy in the differentiation of benign and malignant meningioma.
Yue Q; Isobe T; Shibata Y; Kawamura H; Anno I; Matsumura A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1103-9. PubMed ID: 22295694
[TBL] [Abstract][Full Text] [Related]
20. 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components.
Lehnhardt FG; Röhn G; Ernestus RI; Grüne M; Hoehn M
NMR Biomed; 2001 Aug; 14(5):307-17. PubMed ID: 11477651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
